Animal study · Aging · 10 Nov 2026
In Alzheimer brain tissue and in 5xFAD mice, mitochondria-derived vesicles carrying Ggt1 were tied to Alzheimer-like changes in other mice
Source: Nature Aging
What the research found
Nature Aging published a study online on 10 November 2026. Yun Li, Xiaohuan Xia, Yiyan Sun, Kailing Jia, and colleagues report that mitovesicles, a mitochondria-derived subset of extracellular vesicles, were enriched in brain tissue from people with Alzheimer disease and from 5xFAD mice. Giving 5xFAD brain mitovesicles to wild-type mice was tied to Alzheimer-like behavioral and pathological changes, and it accelerated disease progression in Alzheimer-model mice. Release of the vesicles tracked mitochondrial respiratory metabolism. Blocking that release was tied to fewer Alzheimer-like phenotypes in the mice. Proteomics found Ggt1 highly enriched in the 5xFAD vesicles. Lowering Ggt1 expression and activity was tied to fewer Alzheimer-like phenotypes in 5xFAD mice and to a slower course after the vesicles were given. The abstract does not give a sample size or a p value. This is mouse work plus stored human brain tissue. It is not a therapy. DOI 10.1038/s43587-026-01263-3. Not medical advice.
Evidence level: Animal study. Results in animals or cells often don't carry over to people.
More aging news
- In 50 captive zebra finches followed until natural death, a faster epigenetic pace tracked a shorter lifespan, and a one-time age gap did not
- In 5,794 adults in the Mayo Clinic Study of Aging, each extra year of gait age lined up with a 7 percent higher yearly chance of later cognitive impairment
- In 261 people with suspected rapidly progressive dementia, Graus criteria for possible autoimmune encephalitis were 89 percent sensitive and 96 percent specific
- In 37 people on the Alzheimer spectrum and 43 cognitively normal adults, A1C lined up with different resting brain rhythms
- In 4,822 Korean adults, a lower gait score lined up with later dementia at age 65, and the link faded by the mid-80s